Open AccessHepatitis C virus infection in dialysis patients
Author(s) -
Hossein Khedmat,
Mohsen Amini,
Mohammad Ebrahim Ghamar-Chehreh,
Shahram Agah
Publication year - 2014
Publication title -
saudi journal of kidney diseases and transplantation/našrat amraḍ wa zira'aẗ al-kulaẗ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.268
H-Index - 30
eISSN - 2320-3838
pISSN - 1319-2442
DOI - 10.4103/1319-2442.124455
Subject(s) - medicine , contraindication , dialysis , hepatitis c virus , intensive care medicine , ribavirin , hepatitis c , population , immunology , virus , pathology , alternative medicine , environmental health
Despite the introduction of strict hygienic precautions preventing infection spread of hepatitis C virus (HCV) in dialysis settings, this infection is still prevalent among dialysis patients due to procedures making the patients vulnerable to infection through blood contamination. Treatment of HCV infection in dialysis patients is also less successful than that in the non-uremic population due to contraindication of using ribavirin, a main drug, in the infected patients. In this review article we aim to investigate the feasibility of the current antiviral therapies in dialysis patients infected with HCV infection.